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The first goal of this study was to understand the role of calpains in skeletal muscle
protein degradation in cultured cells. We have developed a genetic approach to inhibit
endogenous calpain activity through over-expressing dominant negative m-calpain (DN),
antisense m-calpain (AS) and calpastatin inhibitory domain (CID). We observed that,
under conditions of accelerated degradation (serum withdrawal), inhibition of m-calpain
through DN-m-calpain over-expression caused a 30 % inhibition of total protein
degradation whereas CID over-expression reduced degradation by 63 %. These
constructs did not significantly affect degradation in the presence of serum. These data
indicate that calpains participate in the accelerated degradation associated with serum
withdrawal. Inhibition of calpain also stabilized nebulin, a major structural protein of the
sarcomere. These observations indicate that calpains play significant roles in muscle
protein turnover. Finally, over-expression of antisense m-calpain caused a transient
reduction in m-calpain concentration after which normal m-calpain concentration was
quickly re-established. These observations indicate that m-calpain is a short half-life
protein in muscle cells.
The second goal of this study is to investigate the role of calpain in the mediation
of PARP protein level in differentiating myoblasts. Poly(ADP-ribosyl)ation, catalyzed by
PARP, is involved in various physiological events, such as DNA excision repair, DNA
recombination, DNA replication, cell differentiation, cell growth and transformation, and
apoptosis. A protease participating in PARP turnover could be a significant regulator to
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protein degradation via a common protease might suggest the basis for muscle wasting
and atrophy which characterize in many muscle diseases. We established a genetic
approach to inhibit endogenous calpain activity through over-expressing calpastatin
inhibitory domain (CID). We observed that (1) inhibition of calpain activity increased
PARP concentration when post-confluent myoblasts were cultured with 2 % HS medium,
an inducer of differentiation and (2) inhibition of calpain activity prevented PARP
degradation induced by A23187 and etoposide in differentiating myoblasts. These data
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Chapter I
Introduction
Skeletal muscle is a major tissue of the body, accounting for forty percent of total
body weight in normal adult animals. The accumulation of muscle tissue or muscle
growth depends on both the rate of muscle protein synthesis and the rate of muscle protein
degradation. It is clear that muscle proteins turn over metabolically with half lives ranging
from 2 to 20 days (1) or 5 to 10 % per day. The rate of muscle protein degradation can
vary over a wide range in response to physiological demand (2,3). Therefore, variations in
rate of muscle protein degradation could be a primary cause in regulating the rate of
muscle growth among domestic animals and could, in some instances, be more important
than the rate of muscle synthesis in such regulation. It has been estimated that 15 to 25 %
of the food ingested by domestic animals is used to replace muscle protein that is degraded
during metabolic turnover (4). Therefore, decreasing the rate of muscle protein
degradation would decrease the amount of energy needed for protein replacement and
should lead directly to increases in efficiency with which animals convert ingested
nutrients into edible muscle. Dystrophic and atrophic muscle, those formation involves
dramatic increases in muscle protein degradation, are observed in many types of muscle
diseases. Little is known, however, about the mechanism of muscle protein degradation
and the nature of the proteolytic enzymes responsible for this turnover. Consequently, it is
important to learn what enzymes are involved in intracellular degradation of muscle
proteins.
Muscle diseases was accompanied by a process termed apoptosis (programmed
cell death).Large decreases in protein degradation have been observed as a major change
in many types of muscle diseases. Apoptosis is poorly understood in skeletal muscle but2
some evidence from other tissues indicates that the enzymes which degrade to bulk of
muscle protein (calpains) are responsible for digestion of some proteins involved in
apoptosis (e.g., poly (ADP-ribose) polymerase; PARP).
Poly (ADP- ribosyl)ation has been suggested to be involved in various
physiological events, including DNA excision repair, DNA recombination, DNA
replication, cell differentiation, cell growth and transformation (5), and carcinogeneses in
vivo (5-7). Inhibition of poly(ADP-ribose) formation through control of poly(ADP-
ribose) polymerase (PARP) activity prevents several types of apoptosis (programmed cell
death; 8-10). PARP cleavage is generally a hallmark of apoptosis. However, the enzyme
responsible for PARP cleavage has proved to be unexpectedly controversial. Both
Nicholson's and Lazebnik's groups have reported that caspase-1 (interleukin 1-p-
converting enzyme, ICE) itself is unable to cleave PARP (11,12) even when the protease
was present in a 500-fold molar excess (11). Recent studies by Gu et al. (13), in contrast,
reported that PARP is cleaved by caspase-1, caspase-4 (TX, an ICE homologue), or
Nedd2 (an ICE homologue) when these proteases are present in excess compared to
substrate. A protease, caspase-3 (CPP32/apopain, an ICE homologue), which cleaves
PARP during activation of apoptosis has been independently identified by three labs
(11,14,15). More recently, however, it was reported that PARP can be processed by
calpain in vitro (16). Consequently, it is interesting to know if calpain is involved in the
degradation of PARP in living cells.
It is of considerable interest to assess the role of calpain in apoptosis since this
process has been detected in some muscle diseases. It has been reported that degenerating
fibers in the mdx mouse, aanimal model of Duchenne type muscular dystrophy (DMD),
show an increase in membrane permeability and undergo apoptosis (87). Further,
apoptosis may be involved in early events associated with muscle differentiation (56).
Here, knowledge of the role of calpain in apoptosis will provide further understanding of
muscle disease and growth.3
Calpain and muscle protein degradation
Calpain and calpain family: Ca 1pain (EC 3.4.22.17) is a CC- dependent
cysteine protease. A CC-dependent neutral proteinase in rat brain was first reported in
the early sixties (17,18) and named as calpain several years later. Ca 1pain was first
purified to homogeneity by Imahori's group (19) in 1978. The first calpain large subunit
cDNA was cloned in 1984 and named as chicken u/m-calpain (20) Since then, various
types of calpain subunits and their homologs have been identified and their primary
structures determined by cDNA cloning .In the calpain family (mammals), two ubiquitous
calpain isoforms are well-characterized (A- and m-calpain), and at least 5 tissue-specific
isoforms have been identified (21). Various "atypical" homologies of calpain are also
being reported in lower organisms, such as insects, nematodes, fungi and yeast. All the
members in calpain family share a similar activity domain, similar to other cysteine
proteases such as papain and cathepsin B, H, and L.
Calpain structure and regulation: p- and m-calpain (conventional calpain) are
heterodimeric proteins, including one large subunit (80 kDa) and one small subunit (30
kDa). The large subunit can be sub-divided into four domains: a propeptide domain (I),
an activity domain (II), a regulatory domain (III), and a calcium-binding domain (IV).
The small subunit includes a calcium-binding domain (IV') and a glycine-rich domain (V).
Calpain activity in living cells is highly regulated. Calcium is essential for calpain
activity (conventional type). Both autolysis and phospholipids increase the sensitivity of
calpain to calcium. Autolysis of calpain occurs at the N-terminus of both the large subunit
(domain I) and small subunit (domain V). Bovine skeletal muscle calpain autolyzes into
78 kDa (m-calpain) or 76 kDa (A-calpain) large subunits and an 18 kDa small subunit for
bothand m-calpain (22). The calcium requirement for calpain activity is reduced by the
autolysis and by the presence of phospholipids (phosphatidylinositol -4,5- bisphosphate pip2
> phosphatidylinositol -4- phosphate pip > phosphatidylinositol p) Autolyzed 11 -calpain, in
bovine skeletal muscle, requires 0.6 AM for half-maximal activity; preautolyzed ji- calpain
requires 7.1 AM; autolyzed m-calpain requires 180 aM CC; and preautolyzed m-calpain4
requires 1 mM Ca++. In the presence of PIP2, /2-calpain is active at 100 nM Ca' whereas
m-calpain requires about 10 AM, or higher, Ca' (23). The regulation of calpain activity is
also affected by calpastatin, the endogenous calpain inhibitor. It is present in all cells that
contain calpain. Calpastatin exists predominantly as a polypeptide of 713-718 residues
and inhibits 1-10 mol of calpain/mol of calpastatin. The inhibitory activity is heat-stable,
competitive, specific and reversible, and can be attributed to any of 4 homologous
functional repeats. Although the intact calpastatin may have additional interactions with
calpain, the central consensus sequence (TIPPEYR) of each repeat has been demonstrated
to be necessary and sufficient for specific inhibition of calpain (24-29).
Involvement of calpain in physiological events: Calpain is a multifunctional
protease. Its processing, instead of digestive, activity determines its significant role in a
variety of physiological events. Calpain substrates (23) include cytoskeletal proteins,
actin-binding proteins (fodrin, spectrin, talin, filamin, etc), microtubule-associated
proteins; membrane proteins such as growth factor receptors; enzymes such as kinases,
phophatases and phospholipases; cytokines (interleukin 12); transcription factors (Fos,
Jun); tumor suppressor p53 (21,30); PARP (16); transforming growth factor-I3 in
hepatocytes (TGF-(3) (31). This list is growing quickly. Calpains have been suggested to
be involved in various physiological and pathological events, including myoblast
differentiation (32), muscle protein degradation (23, 34-38), platelet activation (39-41),
muscular dystrophy- or atrophy- associated diseases (42,43), brain-associated diseases
(23), such as ischaemia and Alzheimer's disease, and apoptosis (44-47).
Components, structure and degradation of skeletal muscle: The muscle is
made up of bundles (fascicles) of fibers, each bundle being lined by perimysial connective
tissue. The most obvious structures within the muscle fiber are the myofibrils, which are
the units responsible for contraction and relaxation of the fiber. Each fiber contains up to
8,000 myofibrils and contains two types of protein filaments, actin and myosin. The two
types of filaments support each other through cross-bridges and are themselves supported
by other specialized structures. Repeating units of a myofibril are named sarcomeres.
These are composed of an array of overlapping thick (myosin) and thin (actin) filaments5
between two adjacent Z discs. The plate-like region of a muscle sarcomere is the Z disk.
This consists of a latticework from which the actin thin filament originates. Each of the
myosin filaments is surrounded by a hexagonal lattice of actin filaments. The actin
filaments contain, in addition to actin, two regulatory proteins, troponin and tropomyosin,
and also a strengthening protein, nebulin. The Z disk is composed mainly of the proteins
a-actinin, desmin, vimentin, and synemin, which form intermediate filaments that are
wrapped around the disk and also link adjacent discs together in the longitudinal and
transverse axes. Degradation of myofibrils involves two steps. The first step is to
dissemble myofibril, initiated from Z disk. The second step is to digest individual
myofibrillar proteins into amino acids. The first step is a rate-limiting step. Therefore, to
identify the protease which mediates this step will facilitate controlling of myofibrillar
protein turnover and understanding of the mechanism of myofibril degradation (48).
Previous studies on the involvement of calpain in myofibril degradation:
Evidence that calpains mediate disassembly of the myofibrillar apparatus is quite
compelling. Calpain initiates digestion of individual myofibrillar proteins including desmin,
filamen, C-protein, tropomyosin, troponin T, troponin I, titin, nebulin, vimentin, gelsolin
and vinculin (34,35,49-56). However, calpains do not degrade a-actin, a-actinin or
myosin heavy chain (33,34). Calpains tend to be concentrated in the Z-disk (36), the site
where disassembly begins (57). Calpains are activated by calcium and treatment of
purified myofibrils with calcium causes rapid and complete loss of the Z-disk (58).
Calpains are also activated in conditions of muscle wasting. Increased calpain activity in
muscle has been reported in vitamin E deficiency (42), Duchenne dystrophy (59-62) and
fasting (43). Calpain mRNA concentrations are increased markedly during fasting (37).
The time course for changes in calpain activity corresponds to morphological changes in
muscle (63). Based on these data, Goll et al (57) and others (33,34,37,43,57,62-66) have
proposed that calpain plays a significant role in myofibrillar protein degradation, especially
in the disassembly of the myofibril during early stages of turnover. Degradation of the Z-
disk by calpain is proposed to cause disordering of the three-dimensional architecture of6
the thick and thin filaments in muscle, thus making the exposed myofibril more susceptible
to proteolytic attack by other, less specific proteases (63).
Limitations to the belief that calpains cause myofibrillar protein disassembly are
that the calcium concentrations required for activity are much higher than those which are
physiologically attainable. And, many reports have shown that the proteasome (multi-
catalytic protease) supersedes the role of calpain in myofibrillar protein degradation (67-
72). The proteasome, a large ubiquitous ATP- and ubiquitin-dependent proteolytic
system, is able to degrade actin and myosin in vitro (68). A recent study by Solomon et al
(68) indicated that the proteasome degrades intact monomeric myofibrillar proteins but
not the same proteins when they were associated with other myofibrillar proteins.
Evidence of calpain involvement in apoptosis
Several lines of evidence suggest the involvement of calpain in apoptosis. In
thymocytes, calpain inhibitors PD150606 (10 tiM), E-64d (300 gM), MDL28170 and
calpain inhibitor I (20 pM), prevent dexamethasone-induced apoptosis, but not
valinomycin- and heat-shock-mediated apoptosis (44). In primary cultures of hepatocyte,
calpain inhibitors (I and II) attenuated TGF-P-induced apoptosis (45). Calpain inhibitors
also blocked apoptosis in murine T cell lymphocytes triggered by engagement of the T cell
receptor, but not apoptosis induced by steroids (46). Finally, calpain inhibitors blocked
activation-induced apoptosis of HIV-infected T lymphocytes and restored effective
immune response in these cells in vitro (47).
Involvement and processing of poly(ADP-ribose) polymerase in physiological events
Poly(ADP-ribose) polymerase (PARP): PARP (EC 2.4.2.30) was first reported
by Shizuta's group (89). The purified enzyme is composed of three domains: DNA7
binding, automodification and NAD-binding domains. PARP catalyzes the transfer of the
ADP-ribose moiety from its substrate, NAD+, to a limited number of protein acceptors.
The amino acid involved is glutamic acid and its carboxyl group is esterified through the
OH-group on C-1 of ADP-ribose (73). DNA strand breaks are essential for PARP
activation (74,75) and recognition by the enzyme is not sequence-specific (76,77). During
DNA repair, PARP recognizes and binds to DNA strand breaks resulting in the activation
of the enzyme and inaccessibility of the nick for DNA binding enzymes such as DNA
polymerase (78). Automodification of PARP and poly(ADP-ribosyl)ation of the
nucleosomal proteins included either in chromatin architecture or DNA metabolism by
PARP then allows the decondensation of the DNA for access to the damaged region by
repair enzymes (79). Automodification of PARP allows itself to be released from the
DNA damage region and leads to the recondensation of DNA.
Involvement of PARP in physiological events: PARP has been suggested to be
involved in various physiological events, including DNA excision repair, DNA
recombination, DNA replication, cell differentiation, cell growth and transformation (5).
More recently, studies in a variety of cell types undergoing spontaneous or induced
apoptosis have demonstrated that the 116-kDa PARP molecule is cleaved to 36-kDa and
85-kDa fragments, which separate its DNA binding domain (36 kDa) from its NAD-
binding catalytic domain (85 kDa), before or concomitant with degradation of nuclear
DNA into nucleosomal fragments (80-82). Cleaved PARP is a hallmark of apoptosis in
many mammalian cells (83,84), but not all cell types (85,86). Interestingly, the
observation that PARP knockout mice have an apparently normal phenotype except for
skin hyperplasia (85) raised questions about the role of this enzyme in normal cellular
physiology.
Proteases involved in PARP processing: The protease(s) responsible for PARP
cleavage has proven to be controversial. Two groups have reported that caspase-1 (ICE)
itself is unable to cleave PARP (11,12) even when the protease was present in vast
abundance over substrate (11). Recent studies by Gu et al. (13), in contrast, reported that
PARP is cleaved by caspase-1, caspase-4 (TX), or Nedd2 when these proteases are8
present in excess compared to substrate. A protease, caspase-3 (CPP32 /apopain), which
cleaves PARP during activation of apoptosis has been independently identified by three
labs (11,14,15). Interestingly, however, it have been recently reported that PARP can
also be processed by calpain in vitro (16).9
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Abstract
The proteolytic system responsible for degrading myofibrillar proteins in skeletal
muscle is not well-defined. The goal of this study was to evaluate the roles of the calpains
(calcium-dependent proteases) in mediating myofibril degradation. Three strategies to
regulate intracellular calpain activities were developed: over-expression of dominant-
negative m-calpain, antisense m-calpain and over-expression of calpastatin inhibitory
domain (CID). To express these constructs, L8 myoblast cell lines were prepared and
transfected with LacSwitch plasmids which allowed for IPTG-dependent expression of a
gene of interest. Dominant negative (DN) m-calpain and antisense m-calpain were
expressed to specifically inhibit m-calpain-dependent degradation of muscle protein
whereas the CID fragment was expected to inhibit all calpains. Inhibition of calpain
activity stabilized fodrin (non-erythroid spectrin), a well-characterized calpain substrate.
This indicated the strategies we developed to regulate calpain in living cells functioned as
expected. Under conditions of accelerated degradation (serum withdrawal), inhibition of
m-calpain with DN-m-calpain over-expression caused a 30% inhibition of total myotubular
protein degradation whereas CID expression reduced degradation by 63%. These
constructs did not significantly affect degradation in the presence of serum. These data
indicate that calpains participate in the accelerated degradation associated with serum
withdrawal. Inhibition of calpain also stabilized nebulin, a major structural protein of the
sarcomere. These observations indicate that calpains play key roles in muscle protein
turnover. Finally, over-expression of antisense m-calpain caused a transient reduction in
m-calpain concentration after which normal m-calpain concentration was quickly re-
established. These observations indicate that m-calpain is a short half-life protein in
muscle cells.
Key words: calpain, muscle, protein degradation, fodrin, nebulin19
Introduction
Skeletal muscle represents the largest pool of labile protein in the body. Within this
pool, the myofibrillar proteins account for the bulk of skeletal muscle protein and, during
diseases or starvation, these proteins are mobilized to nourish the entire organism. These
adaptations may be critical to survival. However, there are instances where mobilization is
excessive and wasting ensues. Muscle wasting occurs in cachexia (1,2), immobility (3),
AIDS (4), endocrine disorders (5) and in genetic muscular dystrophies (6-9).
Identification of the rate-limiting mechanism in muscle wasting may provide a target for
intervention.
Two proteolytic systems have been studied with regard to their role in muscle
protein wasting: calpains and the proteasome. Calpains are calcium-activated cysteine
proteases which were originally identified in porcine muscle (10,11). Two ubiquitous
isoforms are well-characterized (g- and m-calpain) and several tissue-specific isoforms
have also been reported (12). Calpains are regulated by a variety of factors. Ubiquitous
calpains require the presence of a 30 kDa small subunit for activity (12), are activated by
calcium and phospholipids (12-15) and are inhibited by calpastatin, a widely-distributed
calpain-specific inhibitor (16-24). Calpastatin possesses four inhibitory domains which
contain a consensus inhibitory sequence (TIPPEYR) which, in itself, is able to specifically
inhibit calpain (17,20-24). A comprehensive analysis of how all regulatory factors interact
to control calpains is needed.
Evidence that calpains mediate disassembly of the myofibrillar apparatus is
compelling. Calpain initiates digestion of individual myofibrillar proteins including desmin,
filamen, C-protein, tropomyosin, troponin T, troponin I, titin, nebulin, vimentin, gelsolin
and vinculin (25-34). However, calpains do not degrade a-actin, a-actinin or myosin
heavy chain (32,33). Calpains tend to be concentrated in the Z-disk (35), the site where
disassembly begins (36). Calpains are activated by calcium, and treatment of purified
myofibrils with calcium causes rapid and complete loss of the Z-disk (37). Calpains are
\\also activated in conditions of muscle wasting. Increased calpain activity in muscle has20
been reported in vitamin E deficiency (38), Duchenne dystrophy (6-9) and fasting (39).
Calpain mRNA concentrations are increased markedly during fasting (40). The time
course for changes in calpain activity corresponds to morphological changes in muscle
(41). Based on these data, Goll et al. (36) and others (9,32-33,36,39,41,42-44) have
proposed that calpain plays a significant role in myofibrillar protein degradation, especially
in the disassembly of the myofibril during early stages of turnover. Degradation of the Z-
disk by calpain is proposed to cause disordering of the three-dimensional architecture of
the thick and thin filaments in muscle, thus making the exposed myofibril more susceptible
to proteolytic attack by other, less-specific proteases (41).
Limitations to the belief that calpains cause myofibrillar proteins are that the
calcium concentrations required for activity are much higher than those which are
physiologically attainable. In addition, some reports have shown that the proteasome
supersedes the role of calpain in myofibrillar protein degradation (2,45-49). The
proteasome, a large ubiquitous ATP- and ubiquitin-dependent proteolytic system, is able
to degrade actin and myosin in vitro (45). A recent study by Solomon et al. (45) indicated
that the proteasome degrades intact monomeric myofibrillar proteins but not when those
same proteins are associated with other myofibrillar proteins.
Limitations of previous studies are that many have been performed in vitro using
non-specific protease inhibitors. To assess the function played by calpains in living muscle
cells, we developed three genetic strategies to regulate calpain activity in cultured cells:
over-expression of dominant negative m-calpain (DN), antisense m-calpain (AS) and
calpastatin inhibitory domain (CID). Our expectation was that specific regulation of
calpains in living muscle cells would allow the unequivocal identification of calpain
function. Our data indicate that calpains play significant roles in L8 muscle cell protein
degradation and participate in the degradation of nebulin. These data indicate that
inhibition of calpains may effectively slow myofibrillar protein digestion in vivo.21
Materials and Methods
Plasmid construction
Site-directed mutagenesis of rat m-calpain: Full length rat m-calpain cDNA,
subcloned into pT7-7fn phagemid, was generously supplied by John Elce (Queens
University, Canada). Site-directed mutagenesis was performed based on the classic
Kunkel method and Muta-Gene T7 Enzyme Refill Pack Version 2 (Bio-Rad, Hercules, CA
) with slight modification. In brief, a single-stranded DNA template was generated by
super-infection with M13K07 helper phage of CJ 236 (dui- ung, F') host cells containing
pT7-7fn phagemid DNA. Five hours later, the culture was centrifuged at 17,000xg for
15 min at 4°C. The supernatant was collected and incubated for 10 min at 65°C to kill
contaminating host cells. Centrifugation followed and 1/4 volume of 3.5 M ammonium
acetate/20% PEG6000 was added to the supernatant, followed by incubation on ice water
for 30 min. The precipitate was collected by centrifuging twice at 17,000xg for 15 min at
4°C. The pellet was collected and 300 Al TE was added. Purification of single-stranded
DNA template was completed by phenol extraction and ethanol precipitation. The
purified uracil-containing single-stranded DNA template was then stored at -20°C for
further experiments. An oligonucleotide (5'-
AGCCAGAAGCCAGGCGCTCCCAAGGGCTCC-3',synthesized by the Central
Services Lab, Oregon State University) was phosphorylated with T4 polynucleotide
Kinase (Promega, Madison, WI) as a primer for synthesis of a complementary DNA
strand. The synthesis reaction of the complementary DNA strand was performed with a
Muta-Gene T7 Enzyme Refill Pack (Bio-Rad). Successful mutation at 105aa
(cysteinealanine) was verified first by HgaI restriction enzyme digestion (a new
restriction site generated after mutation) followed by DNA sequencing. Finally, dominant
negative full-length rat m-calpain digested with Nco I and Sal I from pT7-7fn phagemid,
was subcloned with Not I linkers into the p0P13CAT (Stratagene, La Jolla, CA)22
expression vector following removal of the CAT gene. This plasmid was designated as
p0P13DN. Correct orientation of the insert was confirmed by DNA sequencing and
restriction enzyme digestion.
Construction of calpastatin inhibitory domain: The calpastatin inhibitory domain
(CID) nucleotide sequence (Figure 2.1, Panel A) was deduced from peptide
EKLGERDDTIPPEYRELLEKKTGV (17) with standard mammalian codon usage. A
translation start codon ATG, Kozak sequence and Not I site were added sequentially to
the 5'-end. A translation stop codon (TGA) and Not I site were added at the 3'-end
(Figure 1, Panel B). This 97-bp full-length single-stranded CID expression construct was
synthesized by the Central Services Lab. Double-stranded full length CID expression
construct was generated by PCR reaction with a forward primer P1 (5'-
TGCGGCCGCCATGGAGAAGCT-3') and a reverse primer P2 (5'-
TGCGGCCGCTCACACGCCGGT-3'). The PCR reaction was completed with 2 mM
MgC12, 0.2 mM dNTP mix, 10 pi Taq DNA polymerase buffer, 2 Al S-S DNA template
(1.3 µg/ µ1), 1(50 pmol) primer P1 and(50 pmol) primer P2, 2 Al Taq DNA
polymerase (5 U/µ1, Promega) and water under 30 cycles of 94°C for 3 min, 55°C for 2
mM and 74°C for 30 sec. Double-stranded CID cDNA was then subcloned by T4 DNA
Ligase (2000 U/gl, New England Biolabs, Beverly, MA) into p0P13CAT expression
vector following removal of the CAT gene, and was designated p0P13CID. Correct
orientation of the insertion was confirmed by DNA sequencing.
Preparation of antisense m-calpain RNA construct: Antisense m-calpain cDNA
was generated by PCR with rat m-calpain full length cDNA as a template and a forward
primer Al (5'-TTGCGGCCGCATGGCGGGCATCGCGATGAAA-3') and a reverse
primer A2 (5'-TTGCGGCCGCCGGCAGGGCGGGGAAGGAAGG-3'). The PCR
reaction was completed with 2 mM MgCl2, 0.2 mM dNTP mix, 10 /21 Taq DNA
polymerase buffer, 80 ng of rat m-calpain cDNA, 1(50 pmol) primer Al and 1 gl (50
pmol) primer A2, 2µl Taq DNA polymerase (5 U/pl, Promega) and water with 30 cycles
of 94°C for 1.5 min, 55°C for 2 min and 74°C for 30 sec. The 165-bp PCR product was23
A. CID nucleotide sequence:
gagaagctgggcgagagggacgacaccatcccccccgagatacagggagctgctggagaagaagaccggc
gtg
B. CID construct:
TGCGGCCGCCATGgagaa
gcgtgTGAGCGGCCGCA
Figure 2.1: CID construct. A: complete CID nucleotide sequence. B. CID construct
containing CID nnucleotide sequence (lower case letters in the middle), Kozak sequence
(bold italic), translation start codon ATG underlined, translation stop codon TGA
underlined, and Not I sites (5' and 3').24
verified on 2 % TAE agarose gel and subcloned in reverse orientation into the Not I site
of p0P13CAT vector following removal of the CAT gene. This was designated as
p0P13AS. Correct orientation of the insert was verified by restriction enzyme digestion
and confirmed by DNA sequencing.
Cell culture
Rat L8 myoblasts and transfectants were cultured in medium containing
Dulbecco's Modified Eagle Medium (DMEM, Gibco, Gaithersburg, MD) with addition of
1000 mg/1D-glucose, 584 mg/L-glutamine, 110 mg/L sodium pyruvate, 4 mg/L
pyridoxine hydrochloride, 3.7 g/L sodium bicarbonate, 100 U/m1Penicillin-Streptomycin
(Gibco) and 10% fetal bovine serum (characterized FBS, Hyclone, Logan, UT). When
cells reached 90-95% confluence, the medium was changed to DMEM complete medium
containing 2% horse serum (Hyclone) in order to obtain fully differentiated myotubes.
The medium was changed every other day for either myoblast or myotubular maintenance.
For long-term storage or subculture, adherent cells were detached from the plate
by trypsinization with 2.5 mg/ml trypsin and 3-min incubation at 37°C. FBS medium was
immediately added to stop further trypsinization. Suspension cells were centrifuged at
1000 rpm for 5 min and the supernatant was discarded. For subculture, the cells were
evenly distributed on new plates. For storage, the cells were placed in vials with a 9:1
ratio of FBS medium and DMSO (Sigma, St. Louis, MO) and stored at - 80°C or in liquid
nitrogen.
Stable co-transfection
Calcium phosphate-based eukaryotic stable cell transfection (50) was performed in
this study with these modifications. In brief, the myoblasts used for transfection were25
recloned or possessed near 100% differentiation ability. On the day prior to transfection,
one 10-cm plate of myoblasts at 80-90% confluence was split into four 10-cm plates. On
the day of transfection, cells were fed with 9.0 ml FBS medium 4 hours prior to calcium
phosphate precipitation. Plasmids to be transfected were purified by CsC1 gradient
centrifugation. Ten Ag of each plasmid to be co-transfected was co-precipitated by
ethanol, followed by a 70% ethanol wash and centrifugation. The DNA pellet was
resuspended in 450 AL sterile water, and 50 AL of 2.5 M sterile CaC12 was added. The
DNA/ CaC12 solution was added with a Pasteur pipet dropwise into 500 gM 2x HeBS
solution containing 282 mM NaC1, 50 mM HEPES acid, and 0.8 mM Na2HPO4, pH 7.05.
The solution was immediately vortexed for 5 sec. After 20 min at room temperature, the
precipitate was distributed evenly over a 10-cm plate of cells. Each co-transfection was
carried out with duplicate plates.
Twelve hours later, cells in one of each duplicate was harvested and stored in a -
80 °C freezer for later selection. The other plate was trypsinized and then the cells were
redistributed with various dilutions. Antibiotic selection with hygromycin B (200 µg/ml,
Gibco) was used for selection of cells containing the p3'SS repressor plasmid, and
geneticin (400 µg/ml, Gibco) was used for selection of the cells transfected with
p0P13CAT, p0P13CID, p0P13DN, or p0P13AS. Co-transfectants were cultured with
FBS medium in addition to hygromycin B and geneticin.
Each clone was transferred from the original plate by a cloning ring made from the
top of a 1-ml sterile blue micropipetter tip when the cell clones were large enough to be
visualized without a microscope. Selected clones were cultured sequentially in a 24-well
plate, a 12-well plate, a 6-well plate, a 5-cm plate and, finally, a 10-cm plate. Twenty
clones of each of the co-transfectants were selected. Each clone was stored in 5 vials in a
-80°C freezer. Co-transfectants were always cultured with antibiotics until the medium
was changed to HS medium.
The clones co-transfected with p3'SS (repressor plasmid, Stratagene) and
p0P13CAT (expression vector) were named L8/PC (plasmid control cell line). The
clones cotransfected with p3'SS and p0P13DN were named L8/DN (dominant negative26
cell line). The clones co-transfected with p3'SS and p0P13CID were named L8 /CID
(calpastatin inhibitory domain cell line). The clones co-transfected with p3'SS and
p0P13AS were named L8/AS (antisense m- calpain cell lines).
Total RNA preparation
The cell lines L8/CID, L8/DN and L8/PC were cultured with FBS medium until
they reached 90% confluence. Then, the cells were cultured for 6 hours, 12 hours and 24
hours while half of the plates were treated with 5 mM isopropyl-P-D-thiogalactoside
(IPTG, Sigma). Duplicate plates were made for both treatment and control. The
guanidinium method (51) for total RNA isolation was completed with slight modification.
Following IPTG treatment, cells were washed with ice-cold PBS once and lysed with 500
AL (5-cm plate) denaturing solution containing 4 M guanidinium thiocyanate, 25 mM
sodium citrate (pH 7.0), 0.1 M 2-ME and 0.5% N-lauroylsarcosine. Lysate was collected
with a disposable cell lifter (Fisher Scientific, Santa Clara, CA) and transferred into a 1.7-
ml microcentrifuge tube. Fifty AL of 2 M sodium acetate (pH 4.0) was added and mixed
throughly by inversion. Five hundred /..iL of fresh acid-saturated phenol (pH 4.3, Fisher)
and 100 ;A, of 49:1 chloroform/isoamylalcohol were added sequentially and rigorously
vortexed following in each step. The suspension was incubated 15 min on ice, followed
by 20 min of centrifugation at 17,000 rpm at 4°C. Then, the upper aqueous phase was
transferred to a fresh tube. The RNA was precipitated by addition of 500(1 vol) of
100% ice-cold isopropanol and incubated at "20° C for at least 30 min. RNA was pelleted
by centrifugation for 10 min at 17,000 rpm, at 4°C. The pellet was dissolved in 150 gl
denaturing solution and precipitated by adding 150 /../L of cold isopropanol with at least 30
min incubation at -20°C. The precipitate was centrifuged again at 17,000 rpm for 10 min
at 4°C. The RNA pellet was washed once with 75% ethanol and incubated 15 min at
room temperature to dissolve residual amounts of guanidinium contaminants. Final
centrifugation was done at 17,000 rpm for 10 min at 4°C. Thirty AL of DEPC-treated H2O27
were added to each RNA pellet after drying of the pellet in a vacuum for 15 min. The
RNA concentration was measured by a DNA/RNA calculator (Gene Quant II, Pharmacia
Biotech, Cambridge CB4 4FJ, England). The quality of RNA was determined by running
regular 1% TAE (0.04 M Tris-acetate, 0.001 M EDTA, and 1.14 mL/L glacial acetic acid)
agarose gel for 6-10 min. RNA aliquots were stored in a "80°C freezer.
Reverse Transcription PCR
RT-PCR assays were performed in two separate steps: reverse transcription to
generate the single-stranded cDNA, and PCR to amplify the specific cDNA. Various
amounts of reverse transcription reaction were used as template in the following PCR
reaction because of the variable copy number of single-stranded cDNAs generated.
Reverse transcription reaction: RNA used for the reverse transcription reaction
was first treated with RQ1 DNase (RNase-free, Promega) to minimize genomic DNA
contamination. The details of the reverse transcription reaction are as follows. Two Ag
of total RNA (plus H2O up to 9.5 AL as a final volume), 2 AL of MMLV reverse
transcriptase reaction buffer (5x), 0.5 AL of RNasin (40 U/AL, Promega), and 1AL of
RQ1 DNase (1 U /uL) were added sequentially and incubated one hour at 37°C. Heat
inactivation was followed for 10 min at 85°C to inhibit DNase activity, and the reaction
mixture was allowed to cool to room temperature. To the reaction, 6 AL of reverse
transcriptase reaction buffer, 6 AL of oligo dT (18 mer, 0.25 µg/AL), 9 AL of DEPC-
treated H2O, 4 AL of dNTP (10 mM each in 10 mM Tris-HCL, pH 7.5), 2 ka, of BSA (2
µg//2L) and 1 AL of M- MLV reverse transcriptase (200U/AL, Promega) were added
sequentially and incubated 2 hours at 37°C. At the end of the reaction, 0.5 AL of RNase
ONE (5 U/AL, Promega) were added and the reaction was continued for another 15 min
at 37°C to digest RNA. This was followed by heat inactivation of RNase and transcriptase
for 5 min at 95°C.28
PCR reaction: The m-calpain RT-PCR reaction consisted of 2µL of reverse
transcription (RT) reaction as a template, 1.5 mM MgCl 0.2 mM dNTP, lx Taq DNA
polymerase buffer, 0.5 AL of Taq DNA polymerase (Promega), 1 ILL of forward primer
RTantiP (5'-GATGAAACTGGCCAAAGA), 1 gl., of reverse primer m-P2 (5'-
AGCTCCTCTGGGACCTCATAGATG-3'). The reaction was performed for 30 cycles at
94°C for 1 min, 55°C for 1.5 min, and 74°C for 1 min. pOP13DN was used as the
template in one reaction as a positive control of the PCR reaction.
The CID (calpastatin inhibitory domain) RT-PCR reaction consisted of 10 ILL of
RT reaction as a template, 1.5 mM MgC12, 0.2 mM dNTP, lx Taq DNA polymerase
buffer, 0.5 AL of Taq DNA polymerase, 1 AL of forward primer P1 (5'-
CATGGAGAAGCTGGGCGA-3'), and 1 AL of reverse primer P2 (5'-
TCACACGCCGGTCTTCTT-3'). The reaction was performed for 30 cycles at 94°C for 1
min, 55°C for 1.5 min, and 74°C for 30 s. p0P13CID was used as the template in one
reaction as a positive control.
The chloramphenicol acetyl transferase (CAT) RT-PCR reaction (positive control
for IPTG induction) consisted of 10 pt of RT reaction as a template, 3 mM MgC12, 0.2
mM dNTP, lx Taq DNA polymerase buffer, 0.5 AiL of Taq DNA polymerase, 1 AL of
forward primer CAT1 (5'-ATGGAGAAAAAAATCACTGGATAT-3'), 1 ill, of reverse
primer CAT2 (5'-TTACGCCCCGCCCTGCCACTCAT-3'). The reaction was performed
for 30 cycles at 94°C for 1 min, 55°C for 1.5 min, and for 74°C for 1 min. pOP13CAT
was used as a template in one reaction as a positive control.
The Lad RT-PCR reaction (negative control for IPTG induction) consisted of 6
1.11., of RT reaction as a template, 1.5 mM MgC12, 0.2 mM dNTP, lx Taq DNA
polymerase buffer, 0.5 AL of Taq DNA polymerase, 1 ill, of forward primer lacP1 (5'-
TGTCGATGGTAGAAGGAAG-3'), and 1 AL of reverse primer lacP2 (5'-
GTGGTTTTTCTTTTCACCAG-3'). The reaction was performed for 30 cycles at 94°C
for 1 min, 54°C for 1.5 min, and 74°C for 1 min. p3'SS was used as the template in one
reaction as a positive control for the PCR reaction. All of the primer solutions contained
50 pmol/AL.29
Fifteen µL of each RT-PCR reaction were used for gel electrophoresis using 1%
TAE agarose gel for the 1100-bp m-calpain RT-PCR product, the 680-bp CAT gene RT-
PCR product and the 600-bp lad RT-PCR product. A 2% TAE agarose gel was used for
the 80-bp CID RT-PCR product.
Measurement of total protein degradation
After 6 days of myotubular differentiation, all of the plates were supplied with 2
pCi/m1 of 3H-tyrosine (NET-127, DuPont NEN, Boston, MA) and 5 mM IPTG was
added to one-half of the plates. Twenty-four hours later, the plates was washed twice
with DMEM medium containing additional 2 mM cold tyrosine (chase) and refilled with
DMEM medium or HS medium. At this time, 1.5 ml of medium were taken from each
plate and radioactivity was measured by scintillation counter. This was designated as the
radioactivity present at time zero. Time zero plates from cultures not treated with IPTG
were described as To whereas time zero plates from cultures treated with IPTG were
described as Toy The rest of the plates were cultured for an additional 6 or 12 hours.
Among those, half continued to be treated with 5 mM IPTG. Six hours (T6 or Ta ) or 12
hours (T12 or T121) later, 1.5 ml of medium from each plate was taken and radioactivity was
measured. From these measurements, total protein degradation at 6 hours (D6 or Da) or
12 hours (D12 or D121) was determined as follows: D6= T6 - T0 ; Da =T6/ - T01 ; D12= T12
T0 ; D121= T121- T01. The percent reduction of total protein degradation (R) caused by
addition of IPTG was calculated as follows: R6 = (D6 -)/D6 x 100; R12 =
/Du x 100.
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Protein extraction from cell culture
The methods used in this study for recovery of cell protein were similar to those
reported by Wang et al (52). Following treatment, medium was removed and attached
cells were washed twice with PBS-EDTA (phosphate-buffered saline plus 100 mM
EDTA). Cells were then lysed at room temperature for 10-15 min with the addition of a
500 /.21 (for 5-cm plate) lysis buffer containing 2% (w/v) SDS, 5 mM EGTA, 5 mM
EDTA, 0.5 mM PMSF (phenylmethysulfonyl fluoride), 10 µg/ml AEBSF (4-(2-
aminoethyl)-benzenesulfonylfluoride), 5 /.4g/m1 TLCK (N-a-p-tosyl-L-lysine chloromethyl
ketone), 0.01% (w/v) leupeptin, 10 /cg/ml TPCK (N-a-p-tosyl-L-phenylalanine
chloromethyl ketone), and 20 mM Tris-HC1 (pH 7.4). One hundred Al of 100% (w/v)
trichloroacetic acid (TCA) was added to the lysate. The DNA aggregate was then
removed. After centrifugation (3600xg for 5 min), pellets were washed with 1 ml of 2.5%
(w/v) TCA. The final pellets were neutralized with 40-80 Al of 3 M Tris base. The
protein concentration was measured by using a protein assay solution (BioRad).
Electrophoresis and Immunoblotting
Thirty to 50 /.cg of protein samples were run on SDS-PAGE (60V, 4 h) in a
PROTEAN II xi Vertical Electrophoresis unit (Bio-Rad) with Tris-glycine running buffer
system (25 mM Tris base, 192 mM glycine, 0.1% (w/v) SDS (pH 8.3) and transferred
onto an OPTITRAN membrane (supported nitrocellulose, Schleicher & Schuell, Keene,
NH) at 0.11 A overnight in a Tris-glycine buffer system with addition of 20 % methanol
and without SDS using a Trans-Blot Cell unit (Bio-Rad). A Bio-Rad high molecular
weight marker was used as a standard. A 4%-12.5% gradient gel with a 100:1 ratio of
acrymide to bis and no stacking gel was used for nebulin protein separation. A Tris-
glycine transfer buffer system with addition of 0.1% SDS and 15% methanol was used for
nebulin transfer at 90 V for 150 min. A 7.5% separating gel and 5% stacking gel were31
used for m- calpain and lad protein separations. A 4-20 % gradient gel and 4 % stacking
gel were used for fodrin protein separation.
The blots were rinsed with TBS (50 mM Tris-base and 150 mM NaCl), blocked by
5 % skim milk in TTBS (TBS plus 0.05% Tween-20) for one hour and probed with
nebulin (1:5000, A-9891, Sigma), lad (1:1000, Stratagene), m-calpain (1:2000), and
spectrin antibodies (1:1000, Chemicon, Temecula, CA) for 2.5 hours. After a 30 min
wash with TTBS following antibody probing, the blots were transferred into a secondary
antibody solution with 1:5000 dilution of either anti-rabbit or anti-mouse IgG (BioRad)
conjugate for at least 30 mM. After another 30-mM wash, the blots were developed with
either an ECL (Amersham, Arlington Heights, IL) or a LumiGLO (KPL, Gaithersburg,
MD) detection system. Blots that have been shown here represent one of the at least three
similar results. Blots (Fig. 2.6 (E)) were quantified by scanning densitometry. The Object
Average method of Image QuaNT, Molecular Dynamics software, was used to determine
the amount of each immune image based on the area and intensity of the blot. To allow
comparison of results of different experiments, each membrane was reprobed with an
internal standard, m-calpain, and results were compensated for variations in these values.
Production of m-calpain antibody
An antipeptidic antibody against the amino-terminal 18-mer segment of pre-
autolysis m-calpain was developed using a synthetic peptide (53),
AGIAAKLAKDREAAEGLGC, conjugated to keyhole limpet hemocyanin and affinity-
purified with Imject Activated Immunogen conjugation Kits (Pierce, Rockford, IL). A
female New Zealand white rabbit, 12-week old, was injected with the immunogen.
Antiserum m- calpain was collected in 4 weeks after injection and was purified with
Sulfolink coupling gel (Pierce, Rockford, IL).32
Statistical analysis
Raw data were analyzed using a two-way ANOVA table within 6 hour and 12
hour groups. The F-test in the ANOVA table was used to evaluate any significant
differences amongst the means. Multiple Range Tests indicate the significant difference
between each others.33
Results
Following transfection, cells were selected for resistance to both hygromycin B
and geneticin. Ability to differentiate was tested for each transfectant. Only the
transfectants which were able to differentiate fully were used for further experiments.
Over-expression of the dominant negative m-calpain and calpastatin inhibitory
domain; detection at the mRNA leveL
To verify that cell lines expressed constructs as desired, several confirmation
studies were completed. In the first of these (Figure 2.2), we assessed effects of IPTG
treatment (12 and 24 hours) on CAT, m-calpain and Lac I mRNAs by RT-PCR in the
L8/PC cell line. IPTG induced expression of CAT without affecting m-calpain or Lad
expression (see Panel A). In the L8/DN cell line, addition of IPTG for 12 or 24 hours
increased expression of m-calpain mRNA but did not affect Lad (Figure 2.2; Panel B).
Of interest, the signal for m-calpain shown in Panel B represents both the endogenous and
dominant negative m-calpain and our expectation is that the increase in signal is due to
synthesis of dominant negative m-calpain. In the third study (Figure 2.2; Panel C), we
assessed effects of IPTG on CID mRNA, m-calpain mRNA and Lad mRNA. IPTG
caused a large increase in CID mRNA but did not affect m-calpain and Lad mRNAs. The
signal for CAT (Panel A) and CID mRNA (Panel C) in the absence of IPTG indicates the
"leakiness" of the LacSwitch expression system. These results demonstrate that
exogenous gene mRNA was inducible by IPTG and stable for at least 24 hours.MI
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Figure 2.2 (A): IPTG induction of exogenous gene expression in L8/PC cell line by RT-
PCR assay. All of the transfectants were grown to 90-100% confluence, after which
IPTG (5 mM) was added to half of the plates and incubated for 12 or 24 hours. RT-PCR
was performed as described in text.12 hours 24 hours
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Figure 2.2 (B): IPTG induction of exogenous gene expression in L8/DN cell line by RT-
PCR assay. All of the transfectants were grown to 90-100% confluence, after which
IPTG (5 mM) was added to half of the plates and incubated for 12 or 24 hours. RT-PCR
was performed as described in text.12 hours 24 hours
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Figure 2.2 (C): IPTG induction of exogenous gene expression in L8/CID cell line by RT-
PCR assay. All of the transfectants were grown to 90-100% confluence, after which
IPTG (5 mM) was added to half of the plates and incubated for 12 or 24 hours. RT-PCR
was performed as described in text.37
Effects of over-expressing dominant negative and antisense m-calpain RNA on m-
calpain at the protein level.
To address the question of whether dominant negative m-calpain would be
expressed at the protein level and whether over-expression of antisense mRNA would
reduce endogenous m-calpain protein concentration, Western blot analysis was performed
(Figure 2.3). In L8/PC and L8/CID cell lines (Panels A and B), addition of IPTG did not
affect m-calpain and Lad concentrations as expected. However, in the L8/DN cell line
(Panel C), total m-calpain protein was increased following addition of IPTG at 8 hours. In
the L8/AS cell line, reduction of endogenous m-calpain protein was almost complete
following IPTG supplementation for 8 hours. Following this, m-calpain concentration
increased gradually. These results demonstrate that m-calpain antisense RNA blocks m-
calpain protein expression successfully within an 8-hour period, and dominant negative m-
calpain was over-expressed at the protein level in transfectants.
Effects of over-expressing of CID, dominant negative m-calpain and antisense m-
RNA on fodrin degradation
Fodrin, a nonerythroid spectrin and a multifunctional protein, is a major
component of the cortical cytoskeleton of most eukaryotic cells (54-55). Fodrin possesses
binding sites for many proteins, including actin, calmodulin, and CD5 (54). Proteolysis of
fodrin by calpain has been observed during several processes. Calpains cleaved fodrin into
150 and 145 kDa fragments following addition of A23187 (CC ionophore) and
maitotoxin, which stimulates calcium influx in both excitable and nonexcitable cells, in SH-
SY5Y neuroblastoma cells and cerebrocortical cultures (52,56). Because fodrin is a well-
characterized calpain substrate, we used fodrin degradation as an index of calpain activity
in rat L8 myotubes.A
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Figure 2.3: Effect of over-expression of various constructs on calpain concentration in
transfectants. Myoblasts were cultured to 90-100% confluence, after which IPTG (5 mM)
was added to each plate. All the plates but '0' were cultured for an additional 8 h, 1 day,
2 days, 3 days, 4 days, 5 days. Western blots were performed and polyclonal rat m-
calpain antibody and polyclonal Lad antibody were used to probe the blots as described in
the text. Panel A: L8/PC cell line; Panel B: L8/CID cell line; Panel C: L8/DN cell line;
Panel D: L8/AS cell line.L8/PC
0 10 1.1.M 20 1.t.M
A23187 (2 h)
L8/CID L8/DN L8/AS
-+ _+ _±
A23187 (1 hour)
280 kDa (spectrin)
-010%an 150/145 kDa
IPTG (5 mM)
280 kDa (Spectrin)
150/145 kDa
39
Figure 2.4: Inhibition of fodrin breakdown product by reduction of calpain activity in
various cell lines. Panel A., Fodrin degradation in L8/PC cell line, cells were cultured with
no A23187 treatment, A23187 (10 gM) for 1 hour, A23187 (20 ilM) for 2 hours,
respectively. Panel B represents fodrin degradation in the presence and absence of IPTG
in the cell lines L8/CID, L8/DN and L8/AS exposed to A23187 (20 gM) for 2 hours.
Monoclonal spectrin antibody (non-erythroid) was used for Western blotting.40
To study the impact of over-expression of CID, DN-m-calpain and m-calpain antisense on
endogenous calpain activity, we examined fodrin breakdown following addition of
A23187 to culture. In L8/PC cells, fodrin was cleaved into 145/150 kDa fragments
following addition of 10 gM or 20 11M A23187 within a one-hour incubation period
(Figure 2.4, Panel A). In L8/CID and L8/DN cell lines, fodrin breakdown following
addition of 20 µM A23187 within 2 hour incubation was reduced by addition of IPTG
(lanes b and d; Panel B, Figure 2.4). These results demonstrate that endogenous calpain
activity is reduced by over-expression of dominant negative m-calpain or calpastatin
inhibitory domain.
Contribution of calpain to total protein degradation
Total myofibrillar protein degradation following serum withdrawal was measured
with a 3H-tyrosine labeling experiment. Figure 2.5, Panel A shows that IPTG did not
affect total protein degradation following serum withdrawal in the L8/PC cell line.
However, in the L8/DN cell line (Figure 2.5, Panel B), total protein degradation was
reduced by 30 % by over-expression of the dominant negative m-calpain for 12 hours. In
the L8/CID cell line (Figure 2.5, Panel C) total protein degradation was reduced by 63 %
following over-expression of calpastatin inhibitory domain for 12 hours. IPTG also
caused a 33% reduction in degradation at 6 hours in the L8/CID cell line. These data
demonstrate that a large portion of myotube protein degradation is mediated by calpains.
Stabilization of nebulin by calpains
Nebulins, a family of giant proteins with molecular masses of 600 to 900 kDa in
various skeletal muscle tissues (53,57), are the sole constituent of a set of long
inextensible longitudinal filaments that span the space between the Z-disk and the distal4
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Figure 2.5 (A): No effect of IPTG on total protein degradation in L8/PC cell line.
Degradation was assessed for 6 hours and 12 hours. Values represent the mean of three
repeats. Triplicates were done for each experiment.42
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Figure 2.5 (B): Statistical significant effect of IPTG on total protein degradation at 12
hours following serum deprivation in L8/DN cell line. Degradation was assessed for 6
hours and 12 hours following serum deprivation. Values represent the mean of three
repeats. Triplicates were done in each experiment.43
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Figure 2.5 (C): Statistical significant effect of IPTG on total protein degradation at 6
hours and 12 hours following serum deprivation in L8/CID cell line. Degradation was
assessed for 6 hours and 12 hours following serum deprivation. Values represent the
mean of three repeats. Triplicates were done in each experiment.44
region of a thin (actin) filament (58). An entire nebulin filament consists of a combination
of 200-, 180-, 40, 35- and 23- kDa sub-fragments (59). In order to determine whether the
calpains degrade this important structural protein, we assessed nebulin degradation in our
cell lines.
Fully differentiated transfectants, L8/PC, L8/CID, L8/DN and L8/AS cell lines,
were divided into two groups. One group was exposed to IPTG for 24 hours (L8/PC,
L8/CID, and L8/DN cell lines). The other group (L8/AS cell line) was exposed to IPTG
for 8 hours. At the end of treatment, all the cells were transferred to serum-free medium
and incubated for 12 more hours in the presence (Figure 2.6, lanes c and d) or absence
(lanes a and b) of IPTG. Western blots were performed and monoclonal nebulin antibody
was utilized as a probe (Figure 2.6; Panel A). Scanning densitometry results are shown in
Panel B. It did not have any impact on the 200-kDa degradation product of nebulin in
L8/PC cells (Panel A). Nebulin was stabilized by 20% following over-expression of DN-
m-calpain, 25% following over-expression of antisense m-calpain, and 33% following
over-expression of CID. These results indicate the involvement of calpain system in
degradation of a key myofibrillar protein in living cells.A
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Figure 2.6: Stabilization of nebulin by reduction of calpain activity. The four cell lines
(L8/PC, L8/DN, L8/AS and L8/CID) were exposed to IPTG (5 mM) for either 24 hours
(PC, DN and CID) or 8 hours (AS), after which nebulin concentration was assessed by
Western blotting (Panels A-D).140
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Figure 2.6 (E): Representing scanning densitometry of data shown in Panels A though D.
Nebulin was stabilized by 20 % following over-expression of DN-m-calpain, 25 %
following over-expression of antisense m-calpain, and 33 % following over-expression of47
Discussion
Accumulation and maintenance of muscle mass is dependent on control of both
protein synthesis and protein degradation. In recent years, interest has focused on
degradation because this process is typically accelerated in a wide variety of pathologic
conditions. For example, degradation is enhanced in cachexia (2), AIDS wasting (4),
various endocrine disorders (5), genetic muscular dystrophies (6-9), and in extended bed
rest (3). Degradation may also be viewed as a constraint to growth (60).
The protease(s) which mediates degradation needs to be identified as this would
provide a logical target for intervention. In this regard, two proteolytic systems have been
studied; the proteasome and calpain. The proteasome is a large multi-functional enzyme
complex which requires ATP for its activity. It is ubiquitously expressed and believed to
degrade a wide range of substrates (22). Several recent studies point to the involvement
of the proteasome in myofibrillar protein degradation (2,45-49); however, it is not clear
whether proteasome is the key rate-limiting protease or is simply one protease in the
pathway of degradation. A recent study by Solomon et al (45) indicated that the
proteasome can degrade monomeric (free) myofibrillar proteins but not the same proteins
when associated with other sarcomeric proteins. These data suggest that another protease
must exist upstream of the proteasome to provide it with monomeric myofibrillar proteins
as substrate.
Several lines of evidence suggest that calpains may be the rate-limiting protease;
however, this has not been established in living cells. In the test tube, calpains degrade
many myofibrillar proteins (e.g. desmin, filamin, C-protein, tropomyosin, troponin T,
troponin I, titin, nebulin, vimentin, gelsolin, and vinculin; 25-34). Changes in activities also
correlate with rates of degradation. Despite this, questions regarding calpain participation
in this process have been raised. For example, high concentrations of Ca++ are required for
activity, at least in vitro, and it is not clear how calpains could ever be activated in the low
Ca' micro-environment of the cell. Thus, the overall goal of this work was to define more48
precisely the role of calpains in protein degradation. Three indices of degradation were
assessed: fodrin degradation, total protein degradation and nebulin degradation.
We utilized cell culture as our study model and three genetic strategies to
manipulate endogenous calpain activities: over-expression of dominant negative m-calpain,
over-expression of calpastatin inhibitory domain, and over-expression of antisense m-
calpain mRNA. We proposed that over-expression of any of these constructs would
inhibit endogenous calpain activities. Either over-expression of dominant negative m-
calpain and antisense m-calpain mRNA was expected to specifically inhibit m- calpain
activity. Over-expression of calpastatin inhibitory domain would inhibit both g- and m-
calpain activities because calpastatin has been shown to inhibit both calpain isoforms
(17,20-24). The ability of these strategies to affect the calpain system was assayed by: 1)
calpain mRNA concentrations were assessed by RT-PCR; 2) m-calpain concentrations
were assessed by Western blot; 3) endogenous calpain activity was evaluated by
monitoring breakdown of fodrin. For analysis of calpain function in myofibrillar protein
breakdown, we measured total protein degradation and tested the stability of nebulin, an
a-actin- and Z-disk-binding protein. Our results showed that exogenous genes (dominant
negative m-calpain, calpastatin inhibitory domain, and antisense m-calpain) were over-
expressed in an inducible manner at the mRNA level (Figure 2.2, Panels B and C) and/or
at the protein level (Figure 2.3, Panels C and D). Endogenous calpain activity was
reduced by over-expression of dominant negative m-calpain and calpastatin inhibitory
domain (Figure 2.4, Panel B).
This work first established that expression of the various constructs regulated the
calpain system as expected. To accomplish this, we evaluated fodrin degradation. Fodrin
is a well- charactered calpain substrate (52,56,61,62). In fact, specific calpain cleavage
sites of fodrin have been identified (63). Our data clearly show that over-expression of
our various constructs (Figure 2.4, Panel B) stabilized fodrin. Hence, these data provide
evidence for our ability to control calpain activity in living muscle cells.
The data above also showed that calpains were involved in total protein
degradation. This was evaluated by release of radiolabeled tyrosine into cell culture49
medium from prelabeled protein. Over-expression of CID in L8/CID cells caused a 63%
reduction in total protein degradation whereas over-expression of dominant negative m-
calpain in L8/DN cells caused only a 30% reduction. Our expectation was that the CID
construct should inhibit both g- and m- calpain whereas the DN-m-calpain construct
should specifically inhibit m-calpain by competing with endogenous intact m-calpain for
substrate. If so, the difference in inhibition caused by these two constructs may
approximate the degradation in L8 cells which is mediated by other calpains (i.e., g-
calpthn). A more direct means of assessing the role of g- calpain in muscle cells would be
to over-express a dominant negative 1.1-calpain construct, similar to that used in this study.
This work is in progress.
Many people believe that calpains are rate-limiting enzymes in myofibrillar protein
degradation (41-43). Yet, other compelling data suggest that the proteasome also
participates in this process (2,45-49). A recent article by Solomon et al. (45 ) indicated
that activity of the proteasome could be secondary to another protease because it was
capable of degrading monomeric myofibrillar proteins, not higher structures. We chose to
investigate the possibility that calpain degrades myofibrillar protein by investigating
nebulin. While intact nebulin is near 600 kDa, it undergoes autofragmentation into 200-,
180-, 40-, 35- and 23- kDa sub-fragments in the presence of 0.1 mM Ca++ (59,60). The
200 kDa fragment was the principle nebulin fragment recovered from muscle preparations
in our experiment. We found that inhibition of calpain activity, whether by over-expression
of CID, AS or DN, stabilized the 200 -kDa fragment of nebulin. These data indicate that
calpain degrades nebulin and therefore, plays an important role in myofibrillar protein
degradation.
One of our cell lines allowed for over-expression of antisense m-calpain mRNA.
We found that production of endogenous m-calpain was almost completely blocked by
over-expression of antisense m-calpain mRNA 8 hours after induced by 5 mM IPTG. This
result differs from those of Zhang et al. (64), who reported that m-calpain was a long-
lived protein. Rapid reduction in m-calpain content indicates that m-calpain turns over in
muscle cells with a half-life of less than 8 hours. The reason Zhang et al. (64) detected a50
half life longer than this could be due to instability of antisense oligomers used in their
study. Also of interest in our study was the ability of L8/AS muscle cells to increase m-
calpain concentrations between 8 and 24 hours of antisense induction. These data imply
that L8 cells are able to "sense" a reduced m-calpain concentration and compensate by
increasing m-calpain synthesis. Maintenance of stable protease concentrations in cells is
needed for normal homeostasis. The transient down-regulation of calpain activity by
antisense may account for the inability of this strategy to measurably affect fodrin
degradation (Figure 2.4, Panel B). Our earlier results have shown that calpain
concentrations remain unchanged despite large changes in muscle cell physiology (e.g.
fasting) and that stable concentrations of calpain are maintained by dramatic changes in
calpain mRNA (40). The observations here are consistent with the belief that muscle cells
regulate protease concentrations precisely.
Earlier studies with L8 cells (65) have documented that serum withdrawal caused
an approximate 20% increase in total protein degradation. It is interesting that
stabilization of nebulin and of total proteins by over-expression of the calpain system was
detectable only under conditions of serum starvation (i.e. accelerated degradation). These
data indicate that calpain may function in degrading proteins under stimulated conditions
but may not account for the normal turnover of proteins. Alternatively, the condition of
accelerated degradation which is caused by serum withdrawal may have created a larger
"target" for regulation and, in this context, ability to detect a role for calpain may be
improved by this strategy.
In conclusion, calpains play definitive roles in protein breakdown in muscle cells.
They degrade fodrin, a well-characterized calpain substrate in vivo and account for a large
proportion of total protein degradation. m-Calpain accounts for roughly 50 % of the
degradation of protein mediated by all calpains. Calpains degrade nebulin, an important
architectural protein of the sarcomere and may be particularly important to degradation
during pathological conditions. In addition to these roles, we also discovered that m-
calpain is a short-lived protein in muscle cells and that L8 cells have the ability to quickly51
adapt to an m-calpain "deficiency". Studies are under way to discover other substrates for
calpains in muscle and to elucidate roles of 1.1-calpdm as well.
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Chapter HI
Regulation of Poly(ADP-ribose) Polymerase by Calpain in Rat LS Myoblasts
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Abstract
In many degradative and metabolic muscle diseases cells die without a marked
inflammatory response. A potential mechanism for accomplishing this is apoptotic cell
death. Involvement of calpain in apoptosis has been observed. More recently, calpain-
dependent degradation of poly(ADP-ribose) polymerase (PARP) in vitro was reported.
PARP cleavage is a hallmark of apoptosis in many types of cells. The goal of this work
was to investigate whether calpain mediates PARP degradation in myoblasts and in the
presence of apoptosis inducers, A23187 and etoposide. We have established a genetic
approach to inhibit endogenous calpain activity by over-expressing calpastatin inhibitory
domain (CID), a calpain endogenous inhibitor. We observed that inhibition of calpain
activity (indicated by over-expressing CID) (1) increased PARP concentration when post-
confluent myoblasts were induced to differentiate; (2) prevented PARP degradation
induced by A23187; and (3) prevented PARP degradation induced by etoposide. These
data demonstrate that calpain is involved in regulation of PARP concentration in
differentiating myoblasts, indicating the possibility that calpain plays a role in apoptosis of
differentiating myoblasts.
Key words: PARP, calpain, apoptosis, calpastatin.60
Introduction
Poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) is bound to chromatin but can
be solubilized with high salt and purified to homogeneity (1). The enzyme protein is
composed of three domains: DNA-binding, automodification and NAD-binding domains.
DNA-strand breaks are essential for PARP activation (2,3). During DNA repair, PARP,
activated by DNA-strand breaks, catalyzes the transfer of an ADP-ribose moiety from its
substrate, NAD, to a limited number of nuclear protein receptors involved in either
chromatin architecture or DNA metabolism (4), such as histone H1, topoisomerase I,
calcium-magnesium-dependent endonuclease and DNA polymerase p (5). Poly (ADP-
ribosyl)ation of nuclear proteins is suggested to facilitate the activity of some DNA repair
enzymes or relaxation of the DNA helix so that the DNA repair enzymes could access the
DNA breaks (6). However, ADP-ribosylation of these enzymes in intact cells has not
been demonstrated (1). Poly(ADP-ribose) synthesis has been suggested to be involved in
various physiological events, including DNA excision repairs, DNA recombination, DNA
replication, cell differentiation, cell growth and transformation (1). More recently, studies
in a variety of cell types undergoing spontaneous or induced apoptosis have demonstrated
that the 116-kDa PARP molecule is cleaved to 36-kDa and 85-kDa fragments, which
separate its DNA-binding domain (36 kDa) from its NAD-binding catalytic domain (85
kDa), before or concomitant with degradation of nuclear DNA into nucleosomal
fragments (7-9). Cleaved PARP is a hallmark of apoptosis in many mammalian cells
(10,11), but not all (12,13). Interestingly, the observation that PARP knockout mice have
an apparently normal phenotype except for skin hyperplasia (12) raised questions about
the role of this enzyme in normal cellular physiology.
Calpains are calcium-activated cysteine proteases which were originally identified
in porcine muscle (14,15). Two ubiquitous isoforms are well-characterized (it- and m-
calpain) and several tissue-specific isoforms have also been reported (16). Calpain
substrates (16) include cytoskeletal proteins; actin-binding proteins (fodrin, spectrin, talin,
filamin); microtubule-associated proteins; membrane proteins such as growth factor61
receptors; enzymes such as kinases, phosphatases and phospholipases; cytokines (e.g.
interleukin 12); transcription factors (Fos, Jun); tumor suppressor p53 (17,18); PARP
(19); transforming growth factor-P (TGF-P) (20). Calpains have been suggested to be
involved in various physiological and pathological events, including myoblast
differentiation (21), muscle protein degradation (22-27), platelet activation (28-30),
muscular dystrophy- or atrophy-associated diseases (31,32), and brain-associated disease
(17) such as ischaemia and Alzheimer's disease. More recently, several lines of evidence
suggest the involvement of calpain in apoptosis.
Evidence that calpain is involved in apoptosis is compelling. In thymocytes,
calpain inhibitors PD150606, E-64d, MDL28170 and calpain inhibitor 1, prevent
dexamethasone-induced apoptosis, but not valinomycin- or heat-shock-mediated apoptosis
(33). In primary cultures of hepatocytes, calpain inhibitors (I and II) attenuated TGF-P-
induced apoptosis (34). Calpain inhibitors also blocked apoptosis in murine T cell
lymphocytes triggered by engagement of the T cell receptor, but not apoptosis induced by
steroids (35). Calpain inhibitors blocked activation-induced apoptosis of HIV-infected T
lymphocytes and restored effective immune response in these cells in vitro (36). In
addition, influx of calcium, causing activation of calpain, has been observed in many types
of apoptosis. Calcium ionophores, A23187 (37,38) and ionomycin (39,40), induce
apoptosis, while calcium channel blocker block the apoptosis process (41,42). Finally,
more recently, degradation of PARP by calpain has been demonstrated in vitro (19).
However, it has not be demonstrated that calpain degrades PARP in living cells.
Therefore, the goal of this study is to determine whether calpain degrades PARP in L8
cultured cells.
Apoptosis is an active form of cellular death, or suicide, which plays an important
physiologic role during organ development and in cellular turnover in differentiated
tissues. Apoptosis has also been demonstrated to occur in response to hypoxic/ischemic
(43), oxidative (44), or drug-induced (45) injuries and is thus involved in disease
pathogenesis. In muscle, apoptosis has been demonstrated in differentiated myocardial
muscle (46), neonatal skeletal muscle (43), skeletal myoblasts in response to injury (47),62
and wound-healing muscle(48).In cell culture studies, apoptosis occurs in differentiated
murine C2 skeletal muscle cells that have been injured by anabolic steroids(47)and
induced by etoposide and puromycin (49), and in mouseC2 C12cells induced by lack of
merosin, a predominant laminin variant in skeletal muscle basement membranes (50).
However, previous studies have shown that the apoptosis pathway and regulators of the
process vary with different types of cells. Whether apoptosis takes place in skeletal
muscleL8cells is still uncertain. Given thatPARPis a hallmark of apoptosis, can
apoptosis inducersA23187and etoposide inducePARPdegradation inL8cells? Does
calpain participate in the mediation ofPARPconcentration under these conditions?
To answer those questions and to overcome non-specificity of calpain inhibitors
which have been used in many studies, we have established a genetic approach to inhibit
endogenous calpain activity by over-expressing the inhibitory domain of calpastatin
(endogenous calpain inhibitor), which is responsible for specific inhibition of calpain (51-
54). We found that inhibition of calpain, through over-expression of calpastatin inhibitory
domain (CID), (1) increased intactPARPconcentration inL8myoblasts; and(2)
stabilizedPARPupon addition of etoposide orA23187.Our data indicate the
involvement of calpain in modulation ofPARPconcentration inL8cells.63
Materials and Methods
Construction of calpastatin inhibitory domain
Construction of calpastatin inhibitory domain was described in detail in Chapter II.
Briefly, the calpastatin inhibitory domain (CID) nucleotide sequence was deduced from
peptide EKLGERDDTIPPEYRELLEKKTGV (51-54) with standard mammalian codon
usage. A translation start codon ATG, Kozak sequence and NotI site were added
sequentially to the 5'-end. A translation stop codon (TGA) and NotI site were added at
the 3'-end. This 97-bp full-length single-stranded CID expression construct was
synthesized by the Central Services Lab at OSU. Double-stranded full length CID
expression construct was generated by PCR reaction with a forward primer PI (5'-
TGCGGCCGCCATGGAGAAGCT-3') and a reverse primer P2 (5'-
TGCGGCCGCTCACACGCCGGT-3'). Double-stranded CID cDNA was subcloned into
p0P13CAT expression vector and designated p0P1301D. Correct orientation of the
insertion was confirmed by DNA sequencing.
Cell culture
Rat L8 myoblasts and transfectants were cultured in medium containing
Dulbecco's Modified Eagle Medium (DMEM, Gibco, Gaithersburg, MD) with addition of
1000 mg/1D-glucose, 584 mg/L-glutamine, 110 mg/L sodium pyruvate, 4 mg/L
pyridoxine hydrochloride, 3.7 g/L sodium bicarbonate, 100 U/ml penicillin-streptomycin
(Gibco) and 10% fetal bovine serum (characterized FBS, Hyclone, Logan, UT). The
medium was changed every other day for either myoblast maintenance.
For long-term storage or sub-culture, adherent cells were detached from the plate
by trypsinization with 2.5 mg/ml trypsin and 3-min incubation at 37°C. Fetal bovine serum64
medium was immediately added to stop further trypsinization. Suspension cells were
centrifuged at 1000 rpm for 5 min and the supernatant was discarded. For sub-culture,
the cells were evenly distributed on new plates. For storage, the cells were placed in vials
with a 9:1 ratio of FBS medium and DMSO (Sigma, St. Louis, MO) and stored at -80°C
or in liquid nitrogen.
Stable co-transfection
Calcium phosphate-based eukaryotic stable cell transfection (55) was performed in
this study with these modifications. The method was described in detail in Chapter II. In
brief, myoblasts used for transfection were recloned or possessed near 100%
differentiation ability. Ten kig of each plasmid to be co-transfected were used in each
transfection. Duplicate plates of each co-transfection were completed. Twelve hours later,
antibiotic selection with hygromycin B (200 µg/ml, Gibco) was used for selection of cells
containing the p3'SS repressor plasmid, and geneticin (400 µg/ml, Gibco) was used for
selection of the cells transfected with p0P13CAT or p0P13CID.
The clones co-transfected with p3'SS (repressor plasmid, Stratagene) and
p0P13CAT (expression vector) were named L8/PC (plasmid control cell line). The
clones co-transfected with p3'SS and pOP13CID were named L8 /CID (calpastatin
inhibitory domain cell line).
Protein extraction from cell culture
The methods used in this study for recovery of cell protein were similar to those
reported by Wang et al (59) and was described in detail in Chapter II. Following
treatment, medium was removed and attached cells were washed twice with PBS-EDTA
(phosphate-buffered saline plus 100 mM EDTA). Cells were then lysed at room65
temperature for 10-15 min with the addition of a 500 ill (for 5-cm plate) lysis buffer (see
Chapter II). The final pellets were neutralized with 40-80 pl of 3 M Tris base. The protein
concentration was measured using a protein assay solution (BioRad).
Electrophoresis and Immunoblotting
Fifty big of protein samples were run on SDS-PAGE (60V, 4 h) in a PROTEAN II
xi Vertical Electrophoresis unit (Bio-Rad, ) with Tris-glycine running buffer system (25
mM Tris base, 192 mM glycine, 0.1% (w/v) SDS (pH 8.3) and transferred onto an
OPTITRAN membrane (supported nitrocellulose, Schleicher & Schuell, Keene, NH) at
0.11 A overnight in a Tris-glycine buffer system with addition of 20 % methanol and
without SDS using a Trans-Blot Cell unit (Bio-Rad, Hercules,CA). A Bio-Rad high
molecular weight marker was used as a standard. A 7.5% separating gel and 5% stacking
gel were used for PARP protein separations.
The blots were rinsed with TBS (50 mM Tris-base and 150 mM NaCl), blocked by
5 % skim milk in TTBS (TBS plus 0.05% Tween-20) for one hour and probed with anti-
PARP mouse monoclonal antibody (clone:C2-10, 1:500, Biomol, Plymouth Meeting, PA)
for 2.5 hours. After a 30 min wash with TTBS following antibody probing, the blots
were transferred into a secondary antibody solution with 1:5000 dilution of anti-mouse
IgG (BioRad) conjugate for at least 30 min. After another 30 min wash, the blots were
developed with either an ECL (Amersham, Arlington Heights, IL) or a LumiGLO (KPL,
Gaithersburg, MD) detection system. All the blots present in this paper represent one of
the at least three similar results. Quantity of each blot determined by scanning
densitometry was described in Chapter II.66
Results
We have observed routinely that induction of myoblast differentiation, especially
post-confluent myoblasts, causes some cells to detach and die. It has been reported that
differentiated apoptotic cells from both C2 and 10TMyo cell lines were found to be
mononucleated (49). These observations indicate that the apoptosis process may be
involved in cellular turnover during transition of myoblasts to myotubes in order to get rid
of extra or non-differentiated myoblasts. To investigate the involvement of calpain in
PARP degradation and apoptosis process in L8 cultured cells, we examined the role that
calpains play in influencing PARP concentration under three conditions: 1) transition of
myoblasts to myotubes without inducers; 2) with apoptosis inducer A23187; and 3) with
apoptosis inducer etoposide.
Effects of over-expressing CH) on PARP concentration in presence of HS
Post-confluent L8/PC and L8/CID myoblasts were cultured with 2 % HS for 12 h,
24 h, and 48 h,respectively, with or without 24-h IPTG (5 mM) preincubation. At the
end of treatment, cell lysates were extracted as described in the Materials and Methods
section. SDS-PAGE was performed and Western blots were followed with anti-PARP
antibody as a probe. Equal amounts of protein samples (50 pg) were loaded. We
observed that over-expression of CID (indicated by IPTG supplement) increased intact
PARP concentration by 33 % (Fig.3.1: Panel A) and 16 % (Fig.3.1: Panel B) when post-
confluent L8/CID myoblasts were cultured with 2% HS medium for 12 h and 24 h,
respectively, with IPTG incubation for 36 h (Panel A) or 48 h (Panel B), respectively. In
contrast, intact PARP concentration did not change under same treatment in L8/PC
myoblasts (Fig.3.1 Panels A and B). The increase in intact PARP concentration was not
observed after 48-h induction of differentiation (Fig.31: Panel C). These observationsB
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Figure 3.1 (Panel A, B, and C): Effect of CID on intact PARP (116 kDa) concentration
following 12-h to 48-h induction of differentiation. Post-confluent L8/PC and L8/CID
myoblasts were cultured with 2 % HS medium for 12 h (A), 24 h (B), or 48 h (C) with or
without 24-h IPTG preincubation. Cell lysates were extracted as described in the text.
SDS-PAGE was performed and a Western blot was followed with anti-PARP monoclonal
antibody.E
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Figure 3.1 (E): Representing scanning densitometry of data shown in Panels A through C
of L8/CID cell line. PARP was stabilized by 33 % following 12-h induction of
differentiation, 16 % following 24-h induction of differentiation. There is no differentiation
between treatment and control after 48-h induction of differentiation.69
indicate that calpains play a role in regulation of intact PARP concentration during the
onset of myoblast differentiation.
Effects of CM on intact PARP concentration following addition of 1µM A23187
The observations that calpain is involved in the regulation of intact PARP
concentration during the onset of differentiation caused us to question whether calpain
plays a role in PARP degradation induced by apoptosis. Calpain inhibitors have been
reported to inhibit apoptosis in some cell lines. Ca++ ionophore (A23187), a mediator of
apoptosis and stimulator of calpain activity, was used in this study.
Post-confluent L8/CB) myoblasts were cultured with DMEM medium (serum
deprivation) with addition of A23187 (1 AM) for 0, 12, 24 h, respectively, with or without
24-h IPTG (5 mM) preincubation. At the end of the treatments, cell lysates were
extracted. SDS-PAGE was performed and a Western blot was followed with anti-PARP
monoclonal antibody as a probe. Equal amounts of protein samples (50 14) were loaded.
We observed that intact (116 kDa) PARP concentration was reduced as a consequence of
incubation with 1 AM A23187 for 12 h and 24 h, respectively (i.e. compare lanes 2 and 4
with lane 1, Fig. 3.2 (A)). However, over-expression of CID (inhibition of calpain)
antagonized the effects of A23187 (see Figure 3.2 (A) lane 3 vs lane 2 and lane 5 vs lane
4). Scanning densitometry (Figure 3.2 (B) results show that inhibition of calpain reduced
10 % or 40 % of PARP degradation following 12- or 24-h incubation with A23187,
respectively. These observations clearly indicate that inhibition of calpain prevents the
destabilization of PARP caused by A23187 treatment.A
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Figure 3.2 (A): Effects of CID on intact PARP concentration following addition of 14M
A23187. Post-confluent L8/CID myoblasts were cultured with DMEM medium following
addition of 1AM A23187 for 0,12, or 24 h, respectively, in presence or absence of 24-h
1PTG (5 mM) preincubation. Cell lysates were extracted (see text). SDS-PAGE was
performed and a Western blot was followed with anti-PARP monoclonal antibody as a
probe.B
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Figure 3.2 (B): Representing scanning densitometry of data shown in Panel A. PARP was
degraded following 12-h or 24-h treatment with A23187, compared to control (0 hour).
PARP was stabilized by 10 % (12 hour) or 40 % (24 hour) following over-expression of
CID.A
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Figure 3.3 (A): Effects of CID on intact (116 kDa) PARP concentration following 48 h
incubation of etoposide. Post-confluent L8/PC and L8/CID myoblasts were cultured with
DMEM medium containing 300 nM etoposide in presence or absence of 24-h IPTG (5
mM) preincubation. Cell lysates were extracted (see text). SDS-PAGE was performed
and a Western blot was followed by using anti-PARP monoclonal antibody as a probe.74
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Figure 3.3 (B): Representing scanning densitometry of data shown in Panel A. PARP
degradation occurs following 48-h treatment with etoposide, compared with 0-h
treatment. Inhibition of calpain by CID was stabilized by 31 %, compared with no
inhibition of calpain.75
Discussion
We have established a genetic approach to inhibit endogenous calpain activity by
over-expressing calpastatin inhibitory domain (CID) in cultured cells. To determine the
inhibition efficiency, we tested the over-expression of CID at the mRNA level by RT-PCR
and examined effects of over-expressing CID on endogenous calpain activity by testing the
prevention of fodrin breakdown products following A23187 treatment (see Chapter 1).
We found that CID mRNA was over-expressed following addition of IPTG (5 mM) to
L8 /CID cells. Furthermore, over-expression of CID inhibited endogenous calpain activity
as indicated by stabilization of fodrin, a typical calpain substrate (27). Todetermine
whether calpain regulates PARP concentration in differentiating myoblasts, we tested (1)
effects of over-expressing CID on intact PARP concentration on the onset of myoblast
differentiation (post-confluent myoblasts cultured with 2% HS); (2) effects of over-
expressing CID on intact PARP concentration following A23187 treatment; and (3)
effects of over-expressing CID on intact PARP following etoposide treatment. Our data
demonstrated that over-expressing CID increased intact PARP concentration in non-
apoptotic cells and stabilized PARP concentration following A23187 and etoposide
treatments (i.e., during apoptosis). These observations indicated that calpains are involved
in regulation of PARP concentration in differentiating myoblasts.
Poly(ADP-ribose) synthesis, catalyzed by PARP, has been suggested to be
involved in various physiological events, including DNA excision repair, DNA
recombination, DNA replication, cell differentiation, cell growth and transformation (1),
and apoptosis (10,11). Cleavage of PARP is a hallmark of apoptosis in many mammalian
cells (10,11). Degradation of PARP in vitro by calpain has been observed and reported
(19). To our knowledge, this is the first report that calpains are involved in regulation of
PARP protein in living cells, which indicates that calpain may be involved in the control of
PARP concentration. This opens up a new area for study of calpain's physiological
function.76
Serum deprivation-induced apoptosis has been demonstrated (61,62). A23187-
and etoposide-mediated apoptosis have also been reported in many cell lines (57-59, 63-
65). Degradation of PARP has been observed in many mammalian cells (10-11). In this
study, we observed that PARP protein level was reduced following serum deprivation plus
A23187 or etoposide in differentiating myoblasts, indicating that apoptosis may occur
upon degradation of PARP. Involvement of calpain in dexamethasone-induced apoptosis
in thymocytes (33), TGF-P-induced apoptosis in hepatocytes (34), T cell receptor-
associated apoptosis is in lymphocytes (35), and activation-induced apoptosis in HIV-
infected T lymphocytes (36) has been demonstrated and reported. Furthermore,
involvement of calpain in serum deprivation-induced apoptosis in C3H/Sol8 muscle
satellite cells (66) and autopsy autolysis-associated apoptosis in cardiac myocytes (67)
have been observed. Consequently, the observations that calpains are involved in steady-
state poly(ADP-ribose) polymerase concentration in serum deprivation plus etoposide- or
A23187- associated differentiating myoblasts leads us to believe that calpain may be
involved in differentiation-associated apoptosis in L8 myoblasts.
Myogenesis-associated apoptosis has been demonstrated in differentiated
myocardial muscle (46), neonatal skeletal muscle (43), skeletal myoblasts in response to
injury (47), and wound-healing muscle (48). In many degradative and metabolic muscle
diseases cells die without a marked inflammatory response (68). A potential mechanism
for this is apoptotic cell death. It has been reported that myonuclear apoptosis is an early
event in the pathology of dystrophin-deficient muscular dystrophy in the mdx mouse (69-
71). However, the mechnism of apoptosis in myogenesis and muscle disease is barely
known and key factors which are involved in the pathway have not been determined yet.
It has been demonstrated that merosin, the predominant laminin variant in skeletal muscle
basement membranes, appears to promote myotube stability by preventing apoptosis prior
to myoblast fusion (49). Insulin-like growth factor-II has been reported to prevent
apoptosis in differentiating myoblasts (72). However, roles of the ICE- or caspase-
families, proven to play more important roles in mediating the process of apoptosis in
general, have not been reported in skeletal muscle apoptosis, although it is known that77
skeletal muscle undergoes apoptosis (i.e., mdx mouse muscle shows evidence of apoptosis
(69-71)). Proteases responsible are not known with certainty. The observation that
calpains participate in PARP degradation indicate a relationship (albeit a very indistinct
relationship, based upon the very preliminary data presented here) to cell death. Roles of
the individual calpains (i.e, 1.1, m-, 1.1-/m- and p94) in control of PARP need now to be
examined.78
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Chapter IV
Overall Summary
Muscle protein degradation is a significant determinant of muscle growth and
muscle size. The first goal of this study was to investigate the role of calpains in skeletal
muscle protein degradation in cultured cells. We have developed a genetic approach to
inhibit endogenous calpain activity through over-expressing dominant negative m-calpain
(DN), antisense m-calpain (AS) and calpastatin inhibitory domain (CID). We observed
that, under conditions of accelerated degradation (serum withdrawal), inhibition of m-
calpain through DN-m-calpain over-expression caused a 30 % inhibition of total
myotubular protein degradation whereas CID over-expression reduced degradation by 63
%. These constructs did not significantly affect degradation in the presence of serum.
These data indicate that calpains participate in the accelerated degradation associated with
serum withdrawal. Inhibition of calpain also stabilized nebulin, a major structural protein
of the sarcomere. These observations indicate that calpains play significant roles in muscle
protein turnover. Finally, over-expression of antisense m-calpain caused a transient
reduction in m-calpain concentration after which normal m- calpain concentration was
quickly re-established. These observations indicate that m-calpain is a short half-life
protein in muscle cells.
The second goal of this study is to investigate the role of calpain, a Ca+-dependent
cysteine protease, in the mediation of PARP protein level in differentiating myoblasts.
Poly(ADP-ribosyl)ation, catalyzed by PARP, is involved in various physiological events,
such as DNA excision repair, DNA recombination, DNA replication, cell differentiation,
cell growth and transformation (5), and apoptosis (86-90). A protease participating in
PARP turnover could be a significant regulator to the events which PARP is involved.
Further, a relationship between apoptosis and myofibrillar protein degradation via a
common protease might suggest the basis for muscle wasting and atrophy which86
characterize in many muscle diseases. We established a genetic approach to inhibit
endogenous calpain activity through over-expressing calpastatin inhibitory domain (CID).
We observed that (1) inhibition of calpain activity increased PARP concentration when
post-confluent myoblasts were cultured with 2 % HS medium, an inducer of
differentiation and (2) inhibition of calpain activity prevented PARP degradation induced
by A23187 and etoposide in differentiating myoblasts. These data demonstrate that
calpain is involved in regulation of PARP in cultured cells.87
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Identification of Discrete Steps in the Process of Muscle Cell Differentiation in Cell
Culture
Jing Huang and Neil Forsberg
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Abstract
The goal of this work was to understand more fully the control of the process of
differentiation in cultured muscle cells. The rationale for this work was that we were
interested in identifying the factors which lead to the gradual loss of differentiation ability
of individual cell lines. L8 myoblasts were cultured at various densities on tissue culture
dishes and interactions between individual clones were assessed. Of the clones which
were studied, many lost their ability to differentiate and we focused our attentions on
these. Non-differentiating myoblast colonies, when cultured adjacent to differentiation-
competent colonies exhibited a variety of responses. First, some myoblasts associated
with the periphery of differentiation-incompetent cells differentiated (i.e., myoblasts
aligned then fused to form myotubes) when cultured adjacent to differentiated cells.
These data indicated that the differentiated colony secreted factor(s) which induced the
adjacent colony to differentiate. Second, in other colonies some differentiation-
incompetent myoblasts aligned in preparation for fusion but never actually fused. These
data indicate that alignment and fusion, while being integral to the process of
differentiation, are independently regulated. While the myoblast-derived factor responsible
for alignment and fusion was not identified in this study, we propose that the use of these
cell lines could provide a useful strategy for its identification and for further examination
of the control of muscle cell differentiation.
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Introduction
Cultured muscle cells have been used extensively to study the process of
differentiation. Differentiation in muscle cell lines is accompanied by remarkable
phenotypic changes (formation of multi-nucleated myoblasts) and biochemical changes
(expression of muscle-specific genes). In our laboratory, we have used L8 myotubes to
study the process of myofibrillar protein degradation [1-3]. However, more-recently, we
have also used this line to examine the roles of individual proteases in the process of
remodeling during muscle cell differentiation [4]. When L8 myoblasts are cultured in
mitogen-rich media (such as Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% fetal bovine serum (HIS)), they proliferate only. However, when
they reach confluence and serum is switched to 2% horse serum (HS), they begin to
differentiate [4]. Differentiation begins with myoblast elongation and alignment, fusion,
formation of small myotubes and, finally, formation of large multi-nucleated myotubes in
which several hundred myonuclei may cluster in well-defined regions of the cell. This
process requires 4-5 days in culture and is thought to be stimulated by the removal of
fibroblast growth factor (FGF) from culture media [5,6,7,8]. FGF has been postulated to
maintain myogenic family proteins (e.g., myogenin) in a phosphorylated state that makes
them unable to complex with E2 proteins and thereby initiate muscle-specific gene
expression. Often, the ability of individual cell lines to differentiate declines following
multiple passages of myotubes. Hence, it is necessary to redone cell lines in order to
maintain lines which maintain high differentiation rates. This loss of the ability to
differentiate has never been fully understood. But, clearly, biochemical or genetic changes
must occur in senescing cell lines which prevent differentiation from occurring. It is
during the recloning process that we have made several observations which illuminate the
mechanisms which coordinate cell-to-cell contact, alignment and fusion; events which
precede the physical aspects of myoblast differentiation and which may be lost during
passage and thereby prevent differentiation.106
The goal of this study was to understand more thoroughly the interactions of L8
myoblast clones in culture. Specifically, we studied the interactions of cells within clones
and how these interactions facilitated the differentiation process. We also examined the
interactions between adjacent clones to determine whether factors from individual colonies
were produced which might influence differentiation of adjacent clones. From our
analysis, we have determined that a differentiation signal originates from the center of each
clones of myoblasts. This signal is diffusible and transmutable. The adjacent non-
differentiating colony could be induced to differentiate. We also identified the discrete
steps in the process of muscle cell differentiation in cell culture.107
Methods
Rat L8 myoblasts (American Type Tissue Collection, Manassas, VA) were
cultured in DMEM (Gibco, Gaithersberg, MD) with addition of 1000mg/1D-glucose, 584
mg/L L- glutamine, 110 mg/1 sodium pyruvate, 4 mg/1 pyridoxine hydrochloride, 3.7 g/1
sodium bicarbonate, 100 U/ml penicillin-streptomycin (Gibco) and 10% (v/v) fetal bovine
serum (characterized FBS, Hyclone, Logan UT). Cells were trypsinized when they
reached 70% confluence and replated to a density as low as 20-30 cells per plate. Ten
plates were prepared for each density. The medium was changed every other day for
myoblasts. The photographs were taken using a Nikon (Model N6000) inverted stage
microscope using 40X magnification.
For the purpose of recloning cell lines, when individual clones were large enough
to be visualized without a microscope, they were transferred and cultured in 24-well, 12-
well, 6-well, 50 mm, and, finally, 100 mm plates, sequentially. For each clone, half were
stored in a -80 °C freezer and another half continued in culture to assess differentiation.
Individual clones were monitored closely following plating. For the purpose of
investigating the interaction between clones, when individual clones were large enough to
be visualized without a microscope, they were cultured with 2 % HS and interactions
between cells within a single clones and between adjacent clones were closely monitored.
Only interactions which were observed repeatedly are presented in this manuscript.108
Results and Discussion
During the process of recloning, we found that some of the new colonies of cells
differentiated readily (e.g. Figure 1) while other colonies had completely lost the ability to
differentiate and, instead, when challenged by mitogen-poor medium, simply maintained a
confluent population of myoblasts (e.g., Figure 2). Clearly, some factor(s) had been lost
from non-differentiating colonies which allowed the normal process of differentiation to
proceed. We reasoned that further study of this phenomenon might prove useful in
identifying the factor(s) which coordinated differentiation or a factor(s) which was lost in
certain cell lines which was also important to the process of differentiation.
We studied the process of differentiation of individual colonies and first noted that,
among colonies which retained ability to differentiate, differentiation always began in the
center of the colony. The process then radiated from the center (e.g., Figure 3) of the
colony to the periphery (Figure 4). These observations indicate one of two possibilities:
1) there is a myoblast-derived differentiation signal which exists at highest concentration at
the center of the colony or 2) cells at the center of the colony are "older" than the nascent
cells of the periphery and, therefore, are chronologically programmed to initiate the
process of differentiation. By mass action, the first possibility would be predicted to occur
at the center of a population of myoblasts in which each cells produced the factor in
similar amounts.
To distinguish between these two possibilities, we reasoned that, if a paracrine-
acting differentiation signal was produced by a differentiation-competent colony, it should
stimulate differentiation of myoblasts on the periphery of nearby colonies. To assess this,
we cultured myoblasts at higher density (100 cells per plate) to enable some colonies to
grow in closer proximity to one another. We found that some fully-differentiated clones
were able to induce changes in adjacent colonies which were quite remarkable and which
provide evidence for the independent regulation of two critical events which precede
differentiation. First, in some cases, a differentiation-competent colony (A) was able to
induce differentiation (alignment and fusion) of adjacent differentiation-incompetent109
colonies (B) (e.g., Figure 5). In this case, differentiation was induced within the peripheral
layer of myoblasts instead of the center of the clone. Our interpretation of this
observation was that such clones lacked an auto-generated differentiation signal and that
this signal was provided by the adjacent differentiation-competent colony. This provides
clear evidence of paracrine control of two processes involved in differentiation of muscle
cells: alignment and fusion. Others have shown that insulin, IGF-I and -II and N-, M-
cadherin are produced by cultured myoblasts and stimulate differentiation [9 -15]. The
myoblast-derived factor(s) inferred by our observations could be IGFs',N-, M- cadherin or
other uncharacterized factors.
Alignment and fusion may be viewed as integral events leading to differentiation;
however, additional observations indicated that differentiation-incompetent myoblasts
could become defective in one or both of these processes. For example, culture of a
differentiated colony (A) adjacent to some differentiation-incompetent colonies caused the
myoblasts of the adjacent colony (B) to align but not fuse (e.g., Figure 6; see arrow). This
suggests that ability to align, while a requisite for fusion, does not automatically lead to
fusion and that differentiation-competent cells produce an alignment signal which initiates
a multi-step process leading to complete differentiation. Additional events must be
regulated following alignment to allow fusion to occur. Some of our clones clearly had
lost this regulatory feature. To support to our observation, It has been reported that M-
cadherin (14,15) and merosin (19) are involved in myoblast fusion of skeletal muscle.
Finally, we also found differentiation-incompetent clones which, despite having
proximity to fully-differentiated colonies, were unable to align or to fuse (Figure 7)These
differentiation-incompetent colonies appear to have lost their ability to recognize the
alignment signal produced by the adjacent differentiation-competent colony. This
alignment signal, which may be one of the well-characterized regulators of muscle cell
differentiation, may also be the signal which induces fusion and subsequent differentiation.
The conclusions of this work are that several steps are involved in the coordination of
myoblast differentiation. First, differentiation-competent myotubes secrete an alignment
factor(s) which induces adjacent myoblasts to align and to fuse. Some cell lines lose their110
ability to differentiate by losing ability to respond to this factor. Several endocrine factors,
such as IGFs [16-18], have been implicated in this control and could serve as the basis for
our observations. Second, fusion does not automatically follow alignment. While a single
factor may regulate both alignment and fusion, we recovered clones capable of aligning
but not fusing. Clearly, some of our cell lines lost their ability to fuse but retained their
ability to align. These data indicate that alignment and fusion are related but
independently-regulated processes. Loss of control at any of these steps could serve as
the basis for the loss of ability of a single clone of muscle cells to differentiate. We
propose the use of these clones could help to unravel the intricate processes intrinsic to
muscle cells which lead to a differentiated phenotype.111
A.1: A clone with fully-differentiated myotubes.M
v.i
r.I114
Figure A.4: A differentiating clone that radiated from the center of the colony to
the periphery115
Figure A.5: One fully-differentiated clone (A) initiates adjacent non-competent
clone (B) to differentiate.116
Figure A.6: A differentiating myoblast clone (A) initiates adjacent non-competent
myoblast clone (B) to elongate.117
Figure A.7: A non-competent myoblast clone could not be effected to differentiate
by an adjacent fully-differentiated myotube clone although they are close to each
other.118
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